113 hasil untuk "Ketty Peris"
Menampilkan 1–20 · 3,75 detik · RSS
-
Artikel Jurnal
Hidradenitis suppurativa characterized by type 2-skewed inflammatory features when associated with atopic dermatitis: critical appraisal of a dupilumab-treated case report
Atopic dermatitis (AD) and hidradenitis suppurativa (HS) are two common chronic inflammatory skin diseases associated with a significant impairment of patients’ quality of life. Although AD and HS are substantially different from a pathogenetic perspective, recent findings have indicated the…
-
Artikel Jurnal
Atopic Dermatitis in the Elderly Population
Atopic dermatitis is a common inflammatory disease with a chronic and relapsing course. Although considered a childhood disease, it is now evident that atopic dermatitis is also common in adulthood and in the elderly population. Atopic dermatitis typically manifests with bilateral and symmetrical…
-
Artikel Jurnal
Upadacitinib as a potential option for the management of paradoxical eczema induced by interleukin-23 inhibitors
Dear Editor, Paradoxical eczema (PE) is defined as de novo onset or flare of eczematous lesions during biologic therapy for psoriasis, regardless of atopic diathesis. PE has been reported with anti-tumor necrosis factor (TNF)-α, anti-interleukin (IL)-17, and more recently with anti-IL-23 agents…
-
Artikel Jurnal
A case of disseminated perforating necrobiosis lipoidica
Abstract Perforating necrobiosis lipoidica (PNL) is a granulomatous inflammatory skin disease that usually occurs in patients with diabetic. We present a case of a female patient affected by a disseminated form of necrobiosis lipoidica.
-
Artikel Jurnal Teks lengkap
Novel Therapeutic Strategies in the Topical Treatment of Atopic Dermatitis
Topical agents that are currently available for the treatment of atopic dermatitis may represent a valid approach in the management of mild or mild–moderate cases, whereas they are often supplemented with systemic therapies for handling more complex or unresponsive cases. The most used compounds…
-
Artikel Jurnal
Scabies‐induced perforating dermatosis successfully treated with low dose methotrexate
Abstract We report the case of an 82‐year‐old diabetic patient, affected by a severe form of scabies‐induced acquired reactive perforating dermatosis, who was successfully treated with low‐dose methotrexate. Acquired reactive perforating dermatosis is a rare cutaneous disease, characterized by the…
-
Artikel Jurnal
Cost of illness of cutaneous squamous cell carcinoma (CSCC)
Objectives: The aim of this study was to estimate the total annual direct costs incurred by the National Health Service for the management and treatment of CSCC and advanced CSCC patients in Italy. Methods: An incidence-based cost of illness (COI) model was developed to estimate direct costs…
-
Artikel Jurnal Teks lengkap
Alopecia Areata Occurring after COVID-19 Vaccination: A Single-Center, Cross-Sectional Study
Limited data concerning the development of autoimmune skin diseases after COVID-19 vaccination are currently available. Recently, a few reports described the development, worsening or recurrence of alopecia areata after the administration of COVID-19 vaccines. High variability in terms of disease…
-
Artikel Jurnal
4P Dermatology: A Shift to a Comprehensive Patient‐Centered Model
ABSTRACT Advances in dermatology are embracing a patient‐centered, proactive approach through the ‘4P model’: Personalized, Predictive, Preventive, and Participatory care. This shift aims to improve treatment efficacy and safety as well as patient's quality of life. This review explores the…
-
Artikel Jurnal
“Skin rashes” and immunotherapy in melanoma: distinct dermatologic adverse events and implications for therapeutic management
Immune checkpoint inhibitors have shown efficacy in the treatment of different cancers by stimulating the antitumoral activity of the patient’s immune system, representing a major breakthrough in the field of cancer therapy. Monoclonal antibodies including anti-cytotoxic T-lymphocyte–associated…
-
Artikel Jurnal Teks lengkap
Pruritus as a Distinctive Feature of Type 2 Inflammation
Pruritus is a common symptom of several skin diseases, both inflammatory and neoplastic. Pruritus might have a tremendous impact on patients’ quality of life and strongly interfere with sleep, social, and work activities. We review the role of type-2 inflammation and immunity in the pathogenesis of…
-
Artikel Jurnal
Successful Lebrikizumab Therapy in Two Patients With Atopic Dermatitis Resistant to Multiple Therapies
ABSTRACT The treatment landscape for moderate‐to‐severe atopic dermatitis (AD) has evolved significantly with the introduction of novel targeted therapies addressing specific pathogenic mechanisms of the disease. Despite this therapeutic revolution, a proportion of patients experience intolerance…
-
Artikel Jurnal
A cost–utility analysis of etanercept for the treatment of moderate-to-severe psoriasis in Italy
Giorgio L Colombo1, Sergio Di Matteo2, Ketty Peris3, Maria Concetta Fargnoli3, Maria Esposito4, Annamaria Mazzotta4, Sergio Chimenti41Faculty of Pharmacy, University of Pavia, Pavia, Italy; 2S.A.V.E. Studi Analisi Valutazioni Economiche, Milan, Italy; 3Department of Dermatology, University of…
-
Artikel Jurnal
Efficacy of topical beta-blockers in the management of EGFR-inhibitor induced paronychia and pyogenic granuloma-like lesions: case series and review of the literature
Nail toxicities, such as paronychia and pyogenic granuloma-like lesions, are well-recognized side effects of epidermal growth factor receptor inhibitor (EGFR-I) therapy that can significantly impair patient’s quality of life and compliance to anticancer treatment. Numerous therapeutic options are…